WWBP stock performance?

Worldwide Biotech & Pharmaceutical Company (WWBP) news stock charts

Worldwide Biotech & Pharmaceutical Company (WWBP/WWBP.OB) Investment Summary:

Worldwide Biotech & Pharmaceutical Company, a biopharmaceutical company, together with its subsidiaries, specializes in the development and marketing of viruses/viral vectors, bio-medicines, external diagnostic reagents, prophylactic vaccines for humans, and oral dosage forms of traditional Chinese medicine. It also engages in developing a hepatitis C vaccine. The company’s products include hepatitis C virus (HCV) produced in-vitro; Elisa kits for HCV antibody detection; anti-HCV medicines; and HCV human vaccines. It also engages in the research, development, and manufacture of over-the-counter traditional Chinese medicines, synthetic medicines, and functional foods; and distribution of medi...
www.worldwidebio.com
94 Employees

WORLDWIDE BIOTECH & PHARMACE (WWBP:OTC Bulletin Board Market)

LAST $0.01 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of 8:10 PM 03/18/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of WORLDWIDE BIOTECH & PHARMACE (WWBP)

OPEN
$0.01
PREVIOUS CLOSE
$0.01
DAY HIGH
$0.01
DAY LOW
$0.01
52 WEEK HIGH
07/2/09 - $0.09
52 WEEK LOW
01/5/10 - $0.0040
MARKET CAP
663.2K
AVERAGE VOLUME 10 D
3.0K
EPS TTM
$-0.03
SHARES OUTSTANDING
53.9M
EX-DATE
11/21/80
P/E TTM
--
DIVIDEND
--
DIVIDEND YIELD
0.00%
K = Thousands  M = Millions  B = Billions

Key developments for WORLDWIDE BIOTECH & PHARMACE (WWBP)

Worldwide Biotech & Pharmaceutical Company Announces Earnings Results for the First Quarter Ended March 31, 2009

Worldwide Biotech & Pharmaceutical Company announced earnings results for the first quarter ended March 31, 2009. For the quarter, the company reported net loss (excluding non-controlling interest) of $194,360. In contrast, the company posted a net loss (excluding non-controlling interest) of $204,323 for the same quarter in the previous year.

Worldwide Biotech & Pharmaceutical Company Auditor Raises 'Going Concern' Doubt

Worldwide Biotech & Pharmaceutical Company filed its 10-K on March 31, 2009 for the period ending December 31, 2008. In this report its auditor, Kempisty & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Worldwide Biotech & Pharmaceutical Company announced delayed 10-Q filing

On 08/13/2008, Worldwide Biotech & Pharmaceutical Company announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Worldwide Biotech & Pharmaceutical Company financial resources

otc, otcbb, pinksheet, WWBP, ob Worldwide Biotech & Pharmaceutical Company

WWBP Competitors

Company Last Change
No competitor information is available for WWBP.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation WWBP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

WWBP

 | 

WWBP transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About Worldwide Biotech & Pharmaceutical Company

WORLDWIDE BIOTECH & PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report

Quote:
Read article

WORLDWIDE BIOTECH & PHARMACEUTICAL CO Files SEC form 10-K, Annual Report

Quote:
Read article

WORLDWIDE BIOTECH & PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report

Quote:
Read article

WORLDWIDE BIOTECH & PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report

Quote:
Read article

WORLDWIDE BIOTECH & PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report

Quote:
Read article

Would you like to leave a comment about Worldwide Biotech & Pharmaceutical Company WWBP/WWBP.OB

Besides Worldwide Biotech & Pharmaceutical Company's Stock there is more great penny stock and market information at Realpennies